Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Terumo Corp ADR (OP: TRUMY )

19.84 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Terumo Corp ADR

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
Why Shares of Orchestra BioMed Jumped Tuesday
The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy. 
Via The Motley Fool
Exposures Product Safety
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga 
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products 
Via News Direct
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... 
Via Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development... 
Via Benzinga
Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
Photo by Mockup Graphics on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.